UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Aprogen’s rheumatoid arthritis biosimilar wins sales approval in Japan
Aprogen Pharmaceuticals said Wednesday that the company’s NI-071 (Original:...
by Lee Han-soo
|
2017-09-27 17:45
라인
Drugmakers need to differentiate big data from ‘large data’
It is necessary for Korean pharmaceutical companies to distinguish big data...
by Nam Doo-hyun
|
2017-09-27 17:44
라인
Exelixis’ kidney cancer drug gains approval in Korea
The Ministry of Food and Drug Safety approved Friday Exelixis’ kidney drug ...
by Marian Chu
|
2017-09-27 17:44
라인
Anticorruption law reduces solicitations, hampers academic activity
Almost a year after the Act on Prohibiting Improper Solicitation and Graft,...
by Choi Gwang-seok
|
2017-09-27 16:36
라인
SNUH to change prescription labels for convenience
The average prescription labels in Korea often warn patients to consume med...
by Constance Williams
|
2017-09-27 15:35
라인
‘Nursing shortage urgently needs state intervention’
South Korea’s nursing shortage should be tackled by a state intervention wi...
by Lee Min-ju
|
2017-09-27 15:13
라인
Social, economic cost of COPD reaches ₩1.4 trillion a year
The domestic social and economic cost of chronic obstructive pulmonary dise...
by Park Gi-taek
|
2017-09-27 14:09
라인
Samsung selected as participant for FDA pilot program
The U.S. Food and Drug Administration said Tuesday it chose nine companies,...
by Marian Chu
|
2017-09-27 13:09
라인
‘K-Hospital Fair 2017’ opens 3-day event
The “K-Hospital Fair 2017” successfully kicked off its three-day event in S...
by Lee Han-soo
|
2017-09-27 11:49
라인
Korean combos, incrementally modified drugs to get insurance benefits
Korean combination drugs for hypertension, diabetes, and hyperlipidemia, an...
by Lee Hye-seon
|
2017-09-27 11:29
라인
Celltrion will use Oracle Health platform to streamline processes
Celltrion will use Oracle Health platforms to help streamline regulatory re...
by Marian Chu
|
2017-09-27 10:47
라인
PNUH, KT to enter Kazakhstan’s’ digital healthcare market
Pusan National University Hospital (PNUH), KT, and Busan Techno Park held a...
by Constance Williams
|
2017-09-26 17:45
라인
Ilyang presents leukemia treatment’s clinical results
Ilyang Pharmaceuticals Tuesday released its phase 3 clinical trial result o...
by Lee Han-soo
|
2017-09-26 17:31
라인
Can Celltrion, Samsung make stable earnings with biosimilar?
Amid the intensifying competition to lower drug prices, market watchers pre...
by Nam Doo-hyun
|
2017-09-26 17:31
라인
Ministry changes dosage recommendation for Bayer’s blood-thinning drug
The Ministry of Food and Drug Safety said Friday it has revised dosage reco...
by Marian Chu
|
2017-09-26 16:24
라인
KHMC to promote AI chat robot-based convenience service for patients
Kyung Hee University Medical Center(KHMC) said Tuesday it would introduce a...
by Constance Williams
|
2017-09-26 16:01
라인
‘Keytruda will beat Opdivo in US because of biomarker’
"Opdivo had gone ahead of Keytruda in America until last year, but Keytruda...
by Nam Doo-hyun
|
2017-09-26 15:57
라인
Recovery rate of heart arrest patients rises 7 times in decade
The survival rate of acute cardiac arrest patients has risen three times, a...
by Kwak Sung-sun
|
2017-09-26 14:32
라인
SNUBH doctors give new chance at life to Cambodian baby
A 10-month-old Cambodian baby who had difficulty breathing from a congenita...
by Constance Williams
|
2017-09-26 13:38
라인
Pfizer launches ‘V-Rep’ for doctors helping smokers quit
Pfizer said Tuesday it has launched a “V-Rep” system, which provides custom...
by Marian Chu
|
2017-09-26 13:30
-
이전
281
282
283
284
285
286
287
288
289
290
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top